Documentation Centre

December 03, 2021
Remnant lipoproteins as a target for atherosclerosis risk reduction. Arterioscler Thromb Vasc Biol. 2021;41:2076-2079
Levin MG

Description of this Publication

Consult publication on external website

By clicking on this link, you will leave the INTERNATIONAL CHAIR ON CARDIOMETABOLIC RISK website

Key Words
Cardiovascular Disease, Epidemiology, Lipids/Lipoproteins